MolNFT v1 · #29832 · protein
Crystal structure of mouse thioredoxin reductase type 2
1ZKQ · Thioredoxin reductase 2, mitochondrial: “Crystal structure of mouse thioredoxin reductase type 2”. X-ray diffraction, 1 ligand (FAD), 5 pockets (best druggability 0.79). MolNFT v1 #29832 on GenesisL1: 3D structure, binding sites and…
- PDB
- 1ZKQ
- Type
- protein
- Length
- 482 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Thioredoxin reductase 2, mitochondrial
- EC
- 1.8.1.9
- UniProt
- Q9JLT4
- Ligands
- FAD
- Pockets
- 5 · best druggability 0.79
Structure
x-ray diffraction · 1 distinct chain · 34% helix, 23% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Thioredoxin reductase 2, mitochondrial (EC 1.8.1.9) | protein | 482 | 34% helix, 23% strand | Q9JLT4 |
Ligands and binding sites
- FAD · Flavin-adenine dinucleotide · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 1084 | 0.79 | 0.81 | 115 | FAD |
| 2 | 378 | 0.64 | 0.79 | 46 | empty |
| 3 | 86 | 0.42 | 0.78 | 21 | empty |
| 4 | 57 | 0.31 | 0.76 | 15 | empty |
| 5 | 62 | 0.29 | 0.74 | 16 | empty |
Compared structures
- 1ZKQ · Crystal structure of mouse thioredoxin reductase type 2 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9JLT4
- Elsewhere: RCSB PDB 1ZKQ · PDBe 1ZKQ · UniProt Q9JLT4
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.